Evidence map›Paper›PMID 31842479›Full record

ArticleSensors (Basel, Switzerland)2019

Development of A Lateral Flow Highway: Ultra-Rapid Multitracking Immunosensor for Cardiac Markers.

Nadezhda A Byzova, Yuri Yu Vengerov, Sergey G Voloshchuk, Anatoly V Zherdev, And Boris B Dzantiev

Open access · goldAbstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Nanomedicines for cardiovascular disease.Nature cardiovascular research · 2023
    Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Nadezhda A ByzovaA.N. Bach Institute of Biochemistry, Research Centre of Biotechnology of the Russian Academy of Sciences, Leninsky prospect 33, 119071 Moscow, Russia.
Yuri Yu VengerovA.N. Bach Institute of Biochemistry, Research Centre of Biotechnology of the Russian Academy of Sciences, Leninsky prospect 33, 119071 Moscow, Russia.
Sergey G VoloshchukMental Health Research Center, Kashirskoye shosse 34, 115522 Moscow, Russia.
Anatoly V ZherdevA.N. Bach Institute of Biochemistry, Research Centre of Biotechnology of the Russian Academy of Sciences, Leninsky prospect 33, 119071 Moscow, Russia.
And Boris B DzantievA.N. Bach Institute of Biochemistry, Research Centre of Biotechnology of the Russian Academy of Sciences, Leninsky prospect 33, 119071 Moscow, Russia.
A N Bach Institute of Biochemistry · RUMental Health Research Center of Russian Academy of Medical Sciences · RU

Funding

Russian Science Foundation 19-14-00370
6 · The paper itself

Abstract

The integration of several controlled parameters within a single test system is experiencing increased demand. However, multiplexed test systems typically require complex manufacturing. Here, we describe a multiplexed immunochromatographic assay that incorporates a conventional nitrocellulose membrane, which is used together with microspot printing, to construct adjacent microfluidic "tracks" for multiplexed detection. The 1 mm distance between tracks allows for the detection of up to four different analytes. The following reagents are applied in separate zones: (a) gold nanoparticle conjugates with antibodies against each analyte, (b) other antibodies against each analyte, and (c) antispecies antibodies. The immersion of the test strip in the sample initiates the lateral flow, during which reagents of different specificities move along their tracks without track erosion or reagent mixing. An essential advantage of the proposed assay is its extreme rapidity (1-1.5 min compared with 10 min for common test strips). This assay format was applied to the detection of cardiac and inflammatory markers (myoglobin, D-dimer, and C-reactive protein) in human blood, and was characterized by high reproducibility (8%-15% coefficient of variation) with stored working ranges of conventional tests. The universal character of the proposed approach will facilitate its use for various analytes.

Indexed as

Biosensing TechniquesDiagnostic Techniques, CardiovascularAntibodiesChromatography, AffinityC-Reactive ProteinFibrin Fibrinogen Degradation ProductsGoldHumansImmunoassayMetal NanoparticlesMyoglobinReagent StripsAntibodiesC-Reactive ProteinFibrin Fibrinogen Degradation Productsfibrin fragment DGoldMyoglobinReagent Stripsbiomarkersdiagnostic testsimmunochromatographic assaymicrofluidicsmultiassaypin applicators

Identifiers

PMID31842479
PMCPMC6970229
OpenAlexW2995751848

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.